**5.3 Evidence from cell cloning studies**

The first reports for the existence of EnSCs on human endometrium came from clonogenic studies which identified epithelial and stromal stem cells (Tanaka, Kyo et al. 2003). By study carried out later on purified single cell suspensions obtained from hysterectomy tissue, 0.22±0.07% of endometrial epithelial cells and 1.25±0.18% of stromal cells formed individual colonies within 15 days (Chan, Schwab et al. 2004). Although both were clonogenic, the stromal stem cells were significantly more clonogenic than epithelial stem cells, and small and large colonies were observed in two types. The number of large colonies was lower than the smaller (0.09% of epithelial cells and 0.02% of stromal cells) and it may be hypothesized that they belong to stem cells population which are rare among other more mature transit amplifying cells. These colonies displayed significantly greater self-renewal capacity compared with the small and loose colonies. This observation lead to the hypothesis that larger colonies belong to endometrial stem/progenitor cells, and the smaller belong to transit amplifying (TA) cells with greater extent of differentiation.

The presence of clonogenic stromal and epithelial cells are also reported in inactive, noncycling endometrium (Schwab, Chan et al. 2005). This study showed similar frequency of clonogenicity for epithelial and stromal cells in different phases of the menstrual cycle or in inactive endometrium. These data further point to the presence of endometrial stem/progenitor cells within basalis layer in higher number than the functionalis layer.

#### **5.4 Side population cells**

Side population (SP) cells are a small fraction of cells within tissues with dye-effluxing properties. They are detected by flowcytometric analysis of pre-incubated cells with DNAbinding dye, Hoechst 33342. This is due to the expression of ABCG2, a plasma membrane transporter. SP cells have been identified from various adult tissues, demonstrating that this phenotype may represent a common feature of adult stem cells. SP cells were identified in short-term culture of two fractions filtered from human endometrial cell suspension (Kato, Yoshimoto et al. 2007). Upper fraction comprised mainly of epithelial (CD9+) cells and the lower fraction contained both epithelial and stromal (CD13+) cells. Further differentiation studies on Matrigel demonstrated the capacity of epithelial side population to differentiate into gland-like structures expressing CD9 and E-cadherin. On the side, cell differentiation

Regeneration process is comprised of endometrial regrowth, angiogenesis and proliferation of endometrial stromal cells. Shedding and regeneration of the endometrial layer during menstruation and regeneration of functional layer may be considered as an indirect evidence for presence of progenitor/ stem cells. This concept was proposed in 1978 by Prianishnikov (Prianishnikov 1978), and then confirmed by following clinical observations (Wood and Rogers 1993), proliferation experiments and demonstration of gland monoclonality (Tanaka, Kyo et al. 2003; Chan, Schwab et al. 2004; Schwab, Chan et al. 2005). In some other species this process is carried out in the form of endometrial growth and apoptosis rather than menstrual cycle. Therefore, this is conceivable that endometrium consists of an active and regenerative population of cells which are known as endometrial progenitor/stem cells (EnSCs). Since endometrium consists of glands, surface epithelium and supportive stroma, the existence of both epithelial and stromal stem/progenitor cells

The first reports for the existence of EnSCs on human endometrium came from clonogenic studies which identified epithelial and stromal stem cells (Tanaka, Kyo et al. 2003). By study carried out later on purified single cell suspensions obtained from hysterectomy tissue, 0.22±0.07% of endometrial epithelial cells and 1.25±0.18% of stromal cells formed individual colonies within 15 days (Chan, Schwab et al. 2004). Although both were clonogenic, the stromal stem cells were significantly more clonogenic than epithelial stem cells, and small and large colonies were observed in two types. The number of large colonies was lower than the smaller (0.09% of epithelial cells and 0.02% of stromal cells) and it may be hypothesized that they belong to stem cells population which are rare among other more mature transit amplifying cells. These colonies displayed significantly greater self-renewal capacity compared with the small and loose colonies. This observation lead to the hypothesis that larger colonies belong to endometrial stem/progenitor cells, and the smaller belong to

The presence of clonogenic stromal and epithelial cells are also reported in inactive, noncycling endometrium (Schwab, Chan et al. 2005). This study showed similar frequency of clonogenicity for epithelial and stromal cells in different phases of the menstrual cycle or in inactive endometrium. These data further point to the presence of endometrial stem/progenitor cells within basalis layer in higher number than the functionalis layer.

Side population (SP) cells are a small fraction of cells within tissues with dye-effluxing properties. They are detected by flowcytometric analysis of pre-incubated cells with DNAbinding dye, Hoechst 33342. This is due to the expression of ABCG2, a plasma membrane transporter. SP cells have been identified from various adult tissues, demonstrating that this phenotype may represent a common feature of adult stem cells. SP cells were identified in short-term culture of two fractions filtered from human endometrial cell suspension (Kato, Yoshimoto et al. 2007). Upper fraction comprised mainly of epithelial (CD9+) cells and the lower fraction contained both epithelial and stromal (CD13+) cells. Further differentiation studies on Matrigel demonstrated the capacity of epithelial side population to differentiate into gland-like structures expressing CD9 and E-cadherin. On the side, cell differentiation

are plausible.

**5.3 Evidence from cell cloning studies** 

**5.4 Side population cells** 

transit amplifying (TA) cells with greater extent of differentiation.

study of lower fraction showed the capacity to differentiate into CD13+ stromal-like clusters. Additionally, to test whether endometrial SP cells reconstitute the endometrial tissue with stromal and glandular structure, they were xenotransplanted into NOG mice (Maruyama 2010). These studies not only demonstrated the presence of endometrial stem/progenitor cells, they have also provided an experimental animal model for endometriosis which is valuable in endometriosis studies.

### **5.5 Evidence from mouse**

Mouse could be used as an experimental model for endometriosis and endometrial stem cell studies. However, the structure and physiology of mouse endometrium is not exactly similar to that of human. The mouse lacks an endometrial basalies layer, and the endometrium does not shed during menstruation but rather it is reabsorbed after the cycle. In spite of these dissimilarities, the murine estrous cycle has characteristics similar to those of human menstrual cycle and then mouse uterus can provide data on the molecular and cellular information for the pathogenesis of endometriosis and normal activity of endometrium tissue.

On this basis, several studies have been conducted to demonstrate the presence of endometrial stem cells in mouse endometrium (Cervello, Martinez-Conejero et al. 2006; Chan and Gargett 2006). For example, label-retaining cells (LRCs) have been shown in the mouse uterus. Label retaining is a technique to identify a stem cell population *in vivo* on the basis of quiescent state of stem/progenitor cells. The cells in this state are able to retain DNA strand incorporated stains such as, 5-bromo-2´-deoxyuridine (BrdU) for a longer period than the active dividing cells. A study conducted by Chan and Gargett showed that 3% of mouse endometrial epithelium after a 56-day chase period and 6% of endometrial stromal cells after an 84-day chase period are LRCs. Also, in another study Cevello et al demonstrated that 9% of stromal cells after 49 days were LRCs and this decreased to 1.7% after 112-day chase period. However, no epithelial LRCs were identified even after 21 days (Cervello, Martinez-Conejero et al. 2006). Presence of LRCs have also been demonstrated in myometrium (Szotek, Chang et al. 2007).

#### **5.6 Endometrial regenerative cells (ERCs) from menstrual blood**

Endometrial stem/progenitor cells have also been obtained from menstrual blood. These cells can be maintained in culture for more than 68 doubling and during this time they are able to retain their markers such as CD9, CD29, CD41a, CD44, CD59, CD73, CD90 and CD105 without karyotypic abnormalities (Musina, Belyavski et al. 2008). Proliferative rate of these cells are also significantly more than mesenchymal stem cells from the source of umbilical cord.

Endometrial regenerative cells (EnRCs) from menstrual blood are different from endometrial stem cells at expression of STRO-1. These cells are also negative for hematopoetic markers such as, CD34, CD45, CD133, but express embryonic stem cell marker, Oct4.

Ease of collection could be considered as an important characteristic of EnRCs which make them more attractive. Karyotypic stability of EnRCs suggests a large scale expansion capability.

Endometrial Stem Cells and Endometriosis 303

positive cells in the basalis layer significantly increase in the stroma (1.5 fold) and in endometrial glands (three fold) compared to functionalis. Musashi-1 is also expressed in

Differentiation potency of endometrial stem cells has been demonstrated in several studies, suggesting their potency to be used as a useful source in cell therapy and tissue engineering. Kato et al used two markers of CD9 and CD13 to show that side population cells can differentiate into endometrial epithelial and stromal cells respectively(Kato, Yoshimoto et al.

Additionally, endometrial stromal cells have the potency to differentiate into chondrocytes when cultured in a defined chondrocyte medium. Also, large putative stromal stem/progenitor cell colonies consist of multipotency by differentiation into mesenchymal lineages-adipocytes, smooth muscle cells, chondrocytes and osteoblasts when cultured in an appropriate differentiation medium. By contrast, the small, loose colonies failed to demonstrate similar differentiation capacity that may suggest these cells are derived from

Endometrial regenerative cells from menstrual blood are also able to differentiate to various cell lineages such as, insulin producer cells ( Li, Chen et al. 2010), osteoblast ( Ai, Mehrabani. 2010) , odontoblasts (Ai, Tabatabaei et al. 2009), and neurons ( Wolff, Gao et al. 2011 and Ai,

EnSCs have been recently used to replace dopaminergic neurons in a murine model of Parkinson's disease (Wolff, Gao et al. 2011). Cardiogenic potential of EnSCs have also been

Endometrium is well known for its profound angiogenic potency which may point to the presence of a highly regenerative back-up layer (Esfandiari, Ai et al. 2007; Esfandiari, Khazaei et al. 2007; Esfandiari, Ai et al. 2008 and Ai, Esfandiari et al 2009a and 2009b). Angiogenesis plays a pivotal role in endometrium regeneration during menstrual cycle. It is also involved in establishment and development of endometriosis lesions (Donnez, Smoes et

It is thought that some embryonic cells in the intermediate mesoderm undergo mesenchymal to epithelial transitions to form the coelomic epithelium that later invaginates to make the paramesonphric or Murrelian ducts (Kobayashi and Behringer 2003). Müllerian ducts comprise of surface epithelium and underlying urogenital ridge mesenchyme which are the source of endometrium and myometrium. A few epithelial and mesenchymal cells are thought to remain in the adult endometrium and contribute to tissue regeneration during menstrual cycle. This small population of stem cells might be subdivided into epithelial and stromal or even more committed sub-lineages or might exist in the form of ultimate uterine stem cells with a capacity to replace all endometrial and myometrial cells.

high levels in endometriosis and endometrial carcinoma (Götte, Wolf et al. 2008).

**5.10 Differentiation ability of endometrial stem cells** 

high-lighted by several studies (Hida, Nishiyama et al. 2008).

**5.11 Endometrial regeneration and angiogenesis** 

**5.12 Sources of endometrial stem/progenitor cells** 

al. 1998; Fujishita, Hasuo et al. 2000).

**5.12.1 Fetal stem cells** 

2007).

TA cells.

Esfandiari et al. 2009a).

### **5.7 Endometrial cancer stem cells**

Presence of specific type of stem cells called cancer stem cells have been pointed at recent years (Bomken, Fišer et al. 2010). Cancer stem cell refers to a subset of tumour cells which are able to self-renew and generate the diverse cells in tumour cell mass. In fact, many features of carcinoma can be explained by the stem cell concept, including clonal origin and heterogeneity of tumors, the mesenchymal influence on cancer behavior, the local formation of precancerous lesions and the plasticity of tumor cells (Miller, Lavker et al. 2005).

A gold standard to evaluate the presence of cancer stem cells is to check their tumorogenicity on immunocompromised mice following serial transplantation. It is now postulated that cancer stem cells are responsible for cancer return after current cancer therapies e.g., radio- or chemotherapy. Recently, presence of endometrial cancer stem cells among endometrial carcinoma cells has been reported (Hubbard, Friel et al. 2009).

#### **5.8 Signalling pathways involved in EnSCs' biology**

Evidences from early studies of human EnSCs revealed the influences of three growth factors on clonogenisity of both epithelial and stromal cells. These are platelet-derived growth factor-BB (PDGF-BB), transforming growth factor-α (TGF-α) and epithelial growth factor (EGF). Basic fibroblast growth factor (b-FGF) was also able to induce clonogenicity on stromal stem cells but was not effective on epithelial cells. This could point to the difference of two cell types in expression of cognate receptor and this may propose two relatively distinct niches for them.

Also in serum-free culture condition, epithelial cells are relying on fibroblast feeder layer for clonogenicity. This may emphasis on the importance of epithelial-stromal interactions.

### **5.9 Endometrial stem cell markers**

No specific marker has been identified for endometrial progenitor stem cells. This may hinder the isolation of EnSCs from surrounding cells utilizing the techniques such as FACS and MACS. Instead, a technique called label-retaining cell (LRC) have been successfully utilized to identify progenitor/stem cells among others in vivo.

Oct-4 is a transcription factor which is crucial for the maintenance of cell pluripotency and is known to be expressed in embryonic stem cells, germ cells, whole embryos at various stages of development and adult stem cells. It is also reported in almost half of the endometrial samples (Matthai, Horvat et al. 2006). Expression of Oct4 mRNA has been detected in all endometrial samples of 89 women in follicular or luteal phase of menstrual cycle (Bentz, Kenning et al. 2010).

Expression of other general stem cell markers such as bcl-2, c-kit (CD117) and CD34 have also been reported on endometrial stem cells (Cho, Park et al. 2004). Haematopoietic stem cell markers (CD34 and CD45) that co-express CD7 and CD56 have also been identified in human endometrial cell suspension that may belong to lymphoid progenitors.

Expression and localization of Musashi-1, a RNA-binding protein, have been evaluated in endometrial, endometriotic and endometrial carcinoma tissue specimens (Götte, Wolf et al. 2008). Musashi-1 is an epithelial progenitor cell marker. It is expressed on endometrial glandular and stromal cells and in proliferative endometrium. The proportion of Musashi-1-

Presence of specific type of stem cells called cancer stem cells have been pointed at recent years (Bomken, Fišer et al. 2010). Cancer stem cell refers to a subset of tumour cells which are able to self-renew and generate the diverse cells in tumour cell mass. In fact, many features of carcinoma can be explained by the stem cell concept, including clonal origin and heterogeneity of tumors, the mesenchymal influence on cancer behavior, the local formation

A gold standard to evaluate the presence of cancer stem cells is to check their tumorogenicity on immunocompromised mice following serial transplantation. It is now postulated that cancer stem cells are responsible for cancer return after current cancer therapies e.g., radio- or chemotherapy. Recently, presence of endometrial cancer stem cells

Evidences from early studies of human EnSCs revealed the influences of three growth factors on clonogenisity of both epithelial and stromal cells. These are platelet-derived growth factor-BB (PDGF-BB), transforming growth factor-α (TGF-α) and epithelial growth factor (EGF). Basic fibroblast growth factor (b-FGF) was also able to induce clonogenicity on stromal stem cells but was not effective on epithelial cells. This could point to the difference of two cell types in expression of cognate receptor and this may propose two relatively

Also in serum-free culture condition, epithelial cells are relying on fibroblast feeder layer for clonogenicity. This may emphasis on the importance of epithelial-stromal interactions.

No specific marker has been identified for endometrial progenitor stem cells. This may hinder the isolation of EnSCs from surrounding cells utilizing the techniques such as FACS and MACS. Instead, a technique called label-retaining cell (LRC) have been successfully

Oct-4 is a transcription factor which is crucial for the maintenance of cell pluripotency and is known to be expressed in embryonic stem cells, germ cells, whole embryos at various stages of development and adult stem cells. It is also reported in almost half of the endometrial samples (Matthai, Horvat et al. 2006). Expression of Oct4 mRNA has been detected in all endometrial samples of 89 women in follicular or luteal phase of menstrual cycle (Bentz,

Expression of other general stem cell markers such as bcl-2, c-kit (CD117) and CD34 have also been reported on endometrial stem cells (Cho, Park et al. 2004). Haematopoietic stem cell markers (CD34 and CD45) that co-express CD7 and CD56 have also been identified in

Expression and localization of Musashi-1, a RNA-binding protein, have been evaluated in endometrial, endometriotic and endometrial carcinoma tissue specimens (Götte, Wolf et al. 2008). Musashi-1 is an epithelial progenitor cell marker. It is expressed on endometrial glandular and stromal cells and in proliferative endometrium. The proportion of Musashi-1-

human endometrial cell suspension that may belong to lymphoid progenitors.

of precancerous lesions and the plasticity of tumor cells (Miller, Lavker et al. 2005).

among endometrial carcinoma cells has been reported (Hubbard, Friel et al. 2009).

**5.8 Signalling pathways involved in EnSCs' biology** 

utilized to identify progenitor/stem cells among others in vivo.

**5.7 Endometrial cancer stem cells** 

distinct niches for them.

Kenning et al. 2010).

**5.9 Endometrial stem cell markers** 

positive cells in the basalis layer significantly increase in the stroma (1.5 fold) and in endometrial glands (three fold) compared to functionalis. Musashi-1 is also expressed in high levels in endometriosis and endometrial carcinoma (Götte, Wolf et al. 2008).

#### **5.10 Differentiation ability of endometrial stem cells**

Differentiation potency of endometrial stem cells has been demonstrated in several studies, suggesting their potency to be used as a useful source in cell therapy and tissue engineering. Kato et al used two markers of CD9 and CD13 to show that side population cells can differentiate into endometrial epithelial and stromal cells respectively(Kato, Yoshimoto et al. 2007).

Additionally, endometrial stromal cells have the potency to differentiate into chondrocytes when cultured in a defined chondrocyte medium. Also, large putative stromal stem/progenitor cell colonies consist of multipotency by differentiation into mesenchymal lineages-adipocytes, smooth muscle cells, chondrocytes and osteoblasts when cultured in an appropriate differentiation medium. By contrast, the small, loose colonies failed to demonstrate similar differentiation capacity that may suggest these cells are derived from TA cells.

Endometrial regenerative cells from menstrual blood are also able to differentiate to various cell lineages such as, insulin producer cells ( Li, Chen et al. 2010), osteoblast ( Ai, Mehrabani. 2010) , odontoblasts (Ai, Tabatabaei et al. 2009), and neurons ( Wolff, Gao et al. 2011 and Ai, Esfandiari et al. 2009a).

EnSCs have been recently used to replace dopaminergic neurons in a murine model of Parkinson's disease (Wolff, Gao et al. 2011). Cardiogenic potential of EnSCs have also been high-lighted by several studies (Hida, Nishiyama et al. 2008).

#### **5.11 Endometrial regeneration and angiogenesis**

Endometrium is well known for its profound angiogenic potency which may point to the presence of a highly regenerative back-up layer (Esfandiari, Ai et al. 2007; Esfandiari, Khazaei et al. 2007; Esfandiari, Ai et al. 2008 and Ai, Esfandiari et al 2009a and 2009b). Angiogenesis plays a pivotal role in endometrium regeneration during menstrual cycle. It is also involved in establishment and development of endometriosis lesions (Donnez, Smoes et al. 1998; Fujishita, Hasuo et al. 2000).

#### **5.12 Sources of endometrial stem/progenitor cells**

#### **5.12.1 Fetal stem cells**

It is thought that some embryonic cells in the intermediate mesoderm undergo mesenchymal to epithelial transitions to form the coelomic epithelium that later invaginates to make the paramesonphric or Murrelian ducts (Kobayashi and Behringer 2003). Müllerian ducts comprise of surface epithelium and underlying urogenital ridge mesenchyme which are the source of endometrium and myometrium. A few epithelial and mesenchymal cells are thought to remain in the adult endometrium and contribute to tissue regeneration during menstrual cycle. This small population of stem cells might be subdivided into epithelial and stromal or even more committed sub-lineages or might exist in the form of ultimate uterine stem cells with a capacity to replace all endometrial and myometrial cells.

Endometrial Stem Cells and Endometriosis 305

The monoclonality of some endometrial lesions (Jimbo, Hitomi et al. 1997; Tamura, Fukaya et al. 1998; Wu, Basir et al. 2003) is consistent with the concept that endometriosis could have a stem cell origin. Furthermore, polyclonal endometriotic lesions may point to repeated seeding of the lesions with cells from other sources such as bone marrow or from establishment of different fragments of shed endometrium containing several stem cells. Although stem cell-based pathogenesis of endometriosis is not fully established the previous studies have demonstrated the role of unfractionated endometrial stem cells to ectopic endometrial growth (Sasson and Taylor 2008). Endometriosis was also generated experimentally by ectopic wild-type endometrial implantation in the peritoneal cavity of hysterectomized LacZ transgenic mice (Du and Taylor 2007). LacZ-expressing stem cells of extrauterine origin were incorporated into the endometriosis implants. These cells were able to differentiate into epithelial and stromal cells at a frequency of 0.04% and 0.1%,

In a study carried out by Leyendecker et al. expression pattern of estrogen receptor, two isoforms of progesterone receptor and P450 aromatase were compared on normal endometrium and ectopic endometriotic implants (Leyendecker, Herbertz et al. 2002). The expression pattern of the endometriotic implants was identical to that of basalis layer of eutopic endometrium and was out of phase with the functionalis layer. This study also demonstrated that more basalis layer was shed in women with endometriosis compared to the normal women. As basalis layer contain endometrial stem/progenitor cells and it is shed in larger extent in endometriosis that is in accordance with the larger volume of retrograde menstrual flow, this may suggest that endometriosis implants results from the

Additionally, it has been postulated that some forms of endometriosis may arise from remnants of fetal müllerian cells which have characteristics of stem cells such as

Thus, stem cell-based pathogenesis of endometriosis could be suggested and this theory could account for the observations that support the cellular origin of ectopic implants.

Ai, J. and D. Mehrabani (2010). "The Potential of Human Endometrial Stem Cells for

Ai, J., F. S. Tabatabaei, et al. (2009). "Human endometrial adult stem cells may differentiate

Alison, M. R., R. Poulsom, et al. (2000). "Cell differentiation: hepatocytes from non-hepatic

Bentz, E. K., M. Kenning, et al. (2010). "OCT-4 expression in follicular and luteal phase

Bomken, S., K. Fišer, et al. (2010). "Understanding the cancer stem cell." British journal of

Buck Louis, G. M., M. L. Hediger, et al. (2011). "Incidence of endometriosis by study

Osteoblast Differentiation." Iranian Red Crescent Medical Journal 12(5): 585-587.

endometrium: a pilot study." Reproductive Biology and Endocrinology 8(1): 38-45.

population and diagnostic method: the ENDO study." Fertility and sterility. 96(2):

retrograde menstruation of endometrial stem/progenitor cells.

into odontoblast cells." Hypothesis 7(1).

adult stem cells." Nature 406: 257.

cancer 103:439-445.

360-365

respectively (Du and Taylor 2007).

multipotency and self-renewal.

**6. References** 

#### **5.13 Bone marrow-derived stem cells as a possible source of endometrial progenitor/stem cells**

Interestingly, regenerative turnover in endometrium is equivalent to that in bone marrow (Fuchs and Segre 2000). Bone marrow is commonly known as a source of hematopoetic and non-hematopoetic stem cells. Hematopoetic stem cells are mainly involved in the homeostasis of cellular part of blood. However, non-hematopoetic stem cells can differentiate into various cell types, e.g., endothelial cells, hepatocytes, neurons, skin, cardiomyocyte, gastrointestinal epithelium (Alison, Poulsom et al. 2000; Mezey, Key et al. 2003; Taylor 2004), suggesting their possible contribution to the maintenance of multiple tissues.

Apart from fetal source of stem cells resideing in adult endometrium which is speculated to account for the endometrium replacement after each menstrual cycle, new observations support the role of bone marrow-derived stem cells at endometrial regeneration.

Migration and presence of donor-derived bone marrow cell to/in endometrium and generation of experimental endometriosis have been reported after murine bone marrow transplantation (Taylor 2004; Du and Taylor 2007). Also, presence of chimerism in the endometrial glands and stroma of four women who received single-antigen HLAmismatched bone marrow transplants can point to the contribution of bone marrow stem cells to the repopulation of the endometrium (Taylor 2004). Bone marrow-derived cells are indistinguishable from endogenous endometrial cells and express glandular and stromal differentiation markers.

Whether bone marrow-derived stem cells are involved in the normal function and regeneration of endometrium or pathogenesis of endometriosis is not clear. However, this theory is appropriately able to explain ectopic endometriosis.

### **5.14 Stem cell-based theory of endometriosis**

Today, a combination theory is more acceptable for the pathogenesis of endometriosis. Evidences for existence of pluripotent endometrial stem cells, and contribution of bone marrow as an alternative source of EnSCs as well as the direct correlation of endometriosis and menstrual retrograde have convinced researchers to propose that stem/progenitor cells are present in the blood that reach the peritoneal cavity (Figueira, Abrão et al. 2011). Endometrial stem cells shed through fallopian tube during menstruation might be responsible for endometriotic implants. Also, this theory could account for the distant ectopic implants, as circulatory stem cells are able to reach peritoneal cavity as well as distant tissues and organs such as brain.

Several experiments have demonstrated that endometrium-derived cells are capable of establishing endometriotic implants (Te Linde and Scott 1950; Ridley and Edwards 1958; D'Hooghe, Bambra et al. 1995). Xenografts of human endometrial tissue or dissociated endometrial cells have been used in immunocompromised mouse to investigate pathogenesis of endometriosis (Grümmer 2006; Masuda, Maruyama et al. 2007). This model provides an appropriate in vivo system to test the possible role of EnSCs in endometriosis. This is further supported by the demonstration of clonogenic cells in a long-term culture derived from a sample of endometriosis tissue (Tanaka, Nakajima et al. 2003).

Interestingly, regenerative turnover in endometrium is equivalent to that in bone marrow (Fuchs and Segre 2000). Bone marrow is commonly known as a source of hematopoetic and non-hematopoetic stem cells. Hematopoetic stem cells are mainly involved in the homeostasis of cellular part of blood. However, non-hematopoetic stem cells can differentiate into various cell types, e.g., endothelial cells, hepatocytes, neurons, skin, cardiomyocyte, gastrointestinal epithelium (Alison, Poulsom et al. 2000; Mezey, Key et al. 2003; Taylor 2004), suggesting their possible contribution to the maintenance of multiple

Apart from fetal source of stem cells resideing in adult endometrium which is speculated to account for the endometrium replacement after each menstrual cycle, new observations

Migration and presence of donor-derived bone marrow cell to/in endometrium and generation of experimental endometriosis have been reported after murine bone marrow transplantation (Taylor 2004; Du and Taylor 2007). Also, presence of chimerism in the endometrial glands and stroma of four women who received single-antigen HLAmismatched bone marrow transplants can point to the contribution of bone marrow stem cells to the repopulation of the endometrium (Taylor 2004). Bone marrow-derived cells are indistinguishable from endogenous endometrial cells and express glandular and stromal

Whether bone marrow-derived stem cells are involved in the normal function and regeneration of endometrium or pathogenesis of endometriosis is not clear. However, this

Today, a combination theory is more acceptable for the pathogenesis of endometriosis. Evidences for existence of pluripotent endometrial stem cells, and contribution of bone marrow as an alternative source of EnSCs as well as the direct correlation of endometriosis and menstrual retrograde have convinced researchers to propose that stem/progenitor cells are present in the blood that reach the peritoneal cavity (Figueira, Abrão et al. 2011). Endometrial stem cells shed through fallopian tube during menstruation might be responsible for endometriotic implants. Also, this theory could account for the distant ectopic implants, as circulatory stem cells are able to reach peritoneal cavity as well as

Several experiments have demonstrated that endometrium-derived cells are capable of establishing endometriotic implants (Te Linde and Scott 1950; Ridley and Edwards 1958; D'Hooghe, Bambra et al. 1995). Xenografts of human endometrial tissue or dissociated endometrial cells have been used in immunocompromised mouse to investigate pathogenesis of endometriosis (Grümmer 2006; Masuda, Maruyama et al. 2007). This model provides an appropriate in vivo system to test the possible role of EnSCs in endometriosis. This is further supported by the demonstration of clonogenic cells in a long-term culture

derived from a sample of endometriosis tissue (Tanaka, Nakajima et al. 2003).

support the role of bone marrow-derived stem cells at endometrial regeneration.

theory is appropriately able to explain ectopic endometriosis.

**5.14 Stem cell-based theory of endometriosis** 

distant tissues and organs such as brain.

**5.13 Bone marrow-derived stem cells as a possible source of endometrial** 

**progenitor/stem cells** 

differentiation markers.

tissues.

The monoclonality of some endometrial lesions (Jimbo, Hitomi et al. 1997; Tamura, Fukaya et al. 1998; Wu, Basir et al. 2003) is consistent with the concept that endometriosis could have a stem cell origin. Furthermore, polyclonal endometriotic lesions may point to repeated seeding of the lesions with cells from other sources such as bone marrow or from establishment of different fragments of shed endometrium containing several stem cells. Although stem cell-based pathogenesis of endometriosis is not fully established the previous studies have demonstrated the role of unfractionated endometrial stem cells to ectopic endometrial growth (Sasson and Taylor 2008). Endometriosis was also generated experimentally by ectopic wild-type endometrial implantation in the peritoneal cavity of hysterectomized LacZ transgenic mice (Du and Taylor 2007). LacZ-expressing stem cells of extrauterine origin were incorporated into the endometriosis implants. These cells were able to differentiate into epithelial and stromal cells at a frequency of 0.04% and 0.1%, respectively (Du and Taylor 2007).

In a study carried out by Leyendecker et al. expression pattern of estrogen receptor, two isoforms of progesterone receptor and P450 aromatase were compared on normal endometrium and ectopic endometriotic implants (Leyendecker, Herbertz et al. 2002). The expression pattern of the endometriotic implants was identical to that of basalis layer of eutopic endometrium and was out of phase with the functionalis layer. This study also demonstrated that more basalis layer was shed in women with endometriosis compared to the normal women. As basalis layer contain endometrial stem/progenitor cells and it is shed in larger extent in endometriosis that is in accordance with the larger volume of retrograde menstrual flow, this may suggest that endometriosis implants results from the retrograde menstruation of endometrial stem/progenitor cells.

Additionally, it has been postulated that some forms of endometriosis may arise from remnants of fetal müllerian cells which have characteristics of stem cells such as multipotency and self-renewal.

Thus, stem cell-based pathogenesis of endometriosis could be suggested and this theory could account for the observations that support the cellular origin of ectopic implants.

#### **6. References**


Endometrial Stem Cells and Endometriosis 307

Götte, M., M. Wolf, et al. (2008). "Increased expression of the adult stem cell marker Musashi

Grümmer, R. (2006). "Animal models in endometriosis research." Human reproduction

Hida, N., N. Nishiyama, et al. (2008). "Novel Cardiac Precursor Like Cells from Human Menstrual Blood Derived Mesenchymal Cells." Stem Cells 26(7): 1695-1704. Hubbard, S. A., A. M. Friel, et al. (2009). "Evidence for cancer stem cells in human

Jimbo, H., Y. Hitomi, et al. (1997). "Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts." The American Journal of Pathology 150(4): 1173-1178. Kato, K., M. Yoshimoto, et al. (2007). "Characterization of side-population cells in human

Kobayashi, A. and R. R. Behringer (2003). "Developmental genetics of the female reproductive tract in mammals." Nature Reviews Genetics 4(12): 969-980. Leyendecker, G., M. Herbertz, et al. (2002). "Endometriosis results from the dislocation of

Li, H. Y., Y. J. Chen, et al. "Induction of Insulin-Producing Cells Derived from Endometrial

Maruyama, T. (2010). "Stem/progenitor cells and the regeneration potentials in the human

Masuda, H., T. Maruyama, et al. (2007). "Noninvasive and real-time assessment of

Matthai, C., R. Horvat, et al. (2006). "Oct-4 expression in human endometrium." Molecular

McLennan, C. E. and A. L. F. H. Rydell (1965). "Extent of endometrial shedding during

Meng, X., T. E. Ichim, et al. (2007). "Endometrial regenerative cells: a novel stem cell

Mezey, É., S. Key, et al. (2003). "Transplanted bone marrow generates new neurons in

Miller, S. J., R. M. Lavker, et al. (2005). "Interpreting epithelial cancer biology in the context

Musina, R. A., A. V. Belyavski, et al. (2008). "Endometrial mesenchymal stem cells isolated

Nazemian, Z., A. Jolly, et al. (2008). "Angiogenesis following three-dimensional culture of

human brains." Proceedings of the National Academy of Sciences of the United

of stem cells: tumor properties and therapeutic implications." Biochimica et

from the menstrual blood." Bulletin of experimental biology and medicine 145(4):

isolated human endometrial stromal cells." International Journal of Fertility and

normal menstruation." Obstetrics & Gynecology 26(5): 605-621.

population." Journal of Translational Medicine 5(1): 57-67.

Biophysica Acta (BBA)-Reviews on Cancer 1756(1): 25-52.

Mesenchymal Stem-like Cells." Journal of Pharmacology and Experimental

reconstructed functional human endometrium in NOD/SCID/ cnull immunodeficient mice." Proceedings of the National Academy of Sciences 104(6):

endometrial carcinoma." Cancer research 69(21): 8241-8248.

normal endometrium." Human Reproduction 22(5): 1214-1223.

basal endometrium." Human Reproduction 17(10): 2725-2736.

uterus." Reproductive Medicine and Biology 9(1): 9-16.

317-329.

update 12(5): 641-649.

Therapeutics 335(3): 817-829.

human reproduction 12(1): 7-10.

States of America 100(3): 1364-1369.

1925-1930.

539-543.

Sterility 2(1): 19-22.

1 in endometriosis and endometrial carcinoma." The Journal of Pathology 215(3):


Cervello, I., J. A. Martinez-Conejero, et al. (2006). "Identification, characterization and co-

Chan, R. W. S. and C. E. Gargett (2006). "Identification of Label Retaining Cells in Mouse

Chan, R. W. S., K. E. Schwab, et al. (2004). "Clonogenicity of human endometrial epithelial

Cho, N. H., Y. K. Park, et al. (2004). "Lifetime expression of stem cell markers in the uterine

D'Hooghe, T. M., C. S. Bambra, et al. (1995). "Intrapelvic injection of menstrual endometrium

Di, W. and S. W. Guo (2007). "The search for genetic variants predisposing women to endometriosis." Current Opinion in Obstetrics and Gynecology 19(4): 395-401. Donnez, J., P. Smoes, et al. (1998). "Vascular endothelial growth factor (VEGF) in

Du, H. and H. S. Taylor (2007). "Contribution of Bone Marrow Derived Stem Cells to

Esfandiari, N., J. Ai, et al. (2007). "Expression of Glycodelin and Cyclooxygenase 2 in Human

Esfandiari, N., M. Khazaei, et al. (2007). "Effect of a statin on an in vitro model of

Ferenczy, A. and C. Bergeron (1991). "Histology of the human endometrium: from birth to senescence." Annals of the New York Academy of Sciences 622(1): 6-27. Figueira, P. G. M., M. S. Abrão, et al. "Stem cells in endometrium and their role in the

Figueira, P. G. M., M. S. Abrão, et al. (2011). "Stem cells in endometrium and their role in the

Fuchs, E. and J. A. Segre (2000). "Stem cells: a new lease on life." Cell (Cambridge) 100(1):

Fujishita, A., A. Hasuo, et al. (2000). "Immunohistochemical study of angiogenic factors in

Gargett, C. E., R. W. S. Chan, et al. (2007). "Endometrial stem cells." Current Opinion in

Giudice, L. C. (2003). Genomics' role in understanding the pathogenesis of endometriosis,

Giudice, L. C. (2006). "Application of functional genomics to primate endometrium: insights

Gogusev, J., J. B. de Joliniere, et al. (1999). "Detection of DNA copy number changes in

human endometriosis by comparative genomic hybridization." Human genetics

into biological processes." Reprod Biol Endocrinol 4(suppl 1): S4.

Endometrial Tissue Following Three dimensional Culture." American Journal of

pathogenesis of endometriosis." Annals of the New York Academy of Sciences

pathogenesis of endometriosis." Annals of the New York Academy of Sciences

endometrium and endometriosis." Gynecologic and obstetric investigation 48(1):

causes endometriosis in baboons (Papio cynocephalus and Papio anubis)\* 1."

undifferentiated markers." Human Reproduction 22(1): 45-51.

and stromal cells." Biology of reproduction 70(6): 1738-1750.

American journal of obstetrics and gynecology 173(1): 125-134.

Endometrium and Endometriosis." Stem Cells 25(8): 2082-2086.

endometriosis." Human Reproduction 13(6): 1686-1690.

endometriosis." Fertility and sterility 87(2): 257-262.

Reproductive Immunology 57(1): 49-54.

Obstetrics and Gynecology 19(4): 377-383.

1221(1): 10-17.

1221(1): 10-17.

21(2): 119-124.

105(5): 444-451.

143-155.

36-44.

endometrium." Fertility and sterility 81(2): 403-407.

Endometrium." Stem Cells 24(6): 1529-1538.

localization of label-retaining cell population in mouse endometrium with typical


**Section 3** 

**Recent Research Trends** 

